Cargando…
Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative
p97, also known as valosin-containing protein (VCP) or Cdc48, plays a central role in cellular protein homeostasis. Human p97 mutations are associated with several neurodegenerative diseases. Targeting p97 and its cofactors is a strategy for cancer drug development. Despite significant structural in...
Autores principales: | Pan, Man, Zheng, Qingyun, Yu, Yuanyuan, Ai, Huasong, Xie, Yuan, Zeng, Xin, Wang, Chu, Liu, Lei, Zhao, Minglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785736/ https://www.ncbi.nlm.nih.gov/pubmed/33402676 http://dx.doi.org/10.1038/s41467-020-20359-x |
Ejemplares similares
-
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adapter NPL4
por: Skrott, Zdenek, et al.
Publicado: (2017) -
Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
por: Majera, Dusana, et al.
Publicado: (2020) -
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma
por: Yoshino, Hirofumi, et al.
Publicado: (2020) -
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways
por: Liu, Yao, et al.
Publicado: (2022) -
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model
por: Serra, Riccardo, et al.
Publicado: (2021)